Patents by Inventor Kenneth E. Schwartz

Kenneth E. Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of subnormal bone mineral density
    Patent number: 7612034
    Abstract: A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on BMD and for increasing BMD in an individual being treated with DHEA, e.g., for treatment of systemic lupus erythematosus (SLE).
    Type: Grant
    Filed: December 28, 2004
    Date of Patent: November 3, 2009
    Assignee: Genelabs Technologies, Inc.
    Inventor: Kenneth E. Schwartz
  • DHEA composition and method
    Patent number: 7045513
    Abstract: Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.
    Type: Grant
    Filed: March 16, 2000
    Date of Patent: May 16, 2006
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jagdish Parasrampuria, Maxine B. Yonker, Kenneth E. Schwartz, Marc J. Gurwith
  • Treatment of subnormal bone mineral density
    Patent number: 6854468
    Abstract: A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on BMD and for increasing BMD in an individual being treated with DHEA, e.g., for treatment of systemic lupus erythematosus (SLE).
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: February 15, 2005
    Assignee: Genelabs Technologies, Inc.
    Inventor: Kenneth E. Schwartz
  • Treatment of SLE with dehydroepiandrosterone
    Publication number: 20030181435
    Abstract: This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.
    Type: Application
    Filed: January 8, 2003
    Publication date: September 25, 2003
    Applicant: Genelabs Technologies, Inc.
    Inventors: Kenneth E. Schwartz, Marc J. Gurwith
  • Treatment of subnormal bone mineral density
    Publication number: 20030158159
    Abstract: A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on BMD and for increasing BMD in an individual being treated with DHEA, e.g., for treatment of systemic lupus erythematosus (SLE).
    Type: Application
    Filed: February 13, 2003
    Publication date: August 21, 2003
    Applicant: Genelabs Technologies, Inc.
    Inventor: Kenneth E. Schwartz
  • Treatment of subnormal bone mineral density
    Patent number: 6605591
    Abstract: A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on BMD and for increasing BMD in an individual being treated with DHEA, e.g., for treatment of systemic lupus erythematosus (SLE).
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: August 12, 2003
    Assignee: Genelabs Technologies, Inc.
    Inventor: Kenneth E. Schwartz
  • Treatment of SLE with dehydroepiandrosterone
    Patent number: 6552010
    Abstract: This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: April 22, 2003
    Assignee: Genelabs Technologies, Inc.
    Inventors: Kenneth E. Schwartz, Marc J. Gurwith
  • Capacitive keyswitch membrane with self contained sense-to-ground capacitance
    Patent number: 4920343
    Abstract: A membrane capacitive keyboard of the type including a first flexible dielectric sheet and a second dielectric sheet having electrically conductive patterns thereon which form an array of capacitors and connecting matrices of drive and sense conductors. The patterns on the sheets include a first array of capacitor plates on an inner surface of the first sheet and a second array of capacitor plates on the outer surface of the second sheet. A third array of electrically floating capacitor plates is formed by a third pattern on the inner surface of the second sheet. The sense conductors are capacitively coupled to ground through coupling capacitor plates connected to the sense conductors and a common capacitor plate overlaying the coupling capacitor plates.
    Type: Grant
    Filed: September 30, 1988
    Date of Patent: April 24, 1990
    Assignee: Honeywell Inc.
    Inventor: Kenneth E. Schwartz